Sildenafil Citrate
Product Images NDC 50436-0036

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 50436-0036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl504360035)

Sildenafil Citrate 50 mg Unit Dose label from Unit Dose Services. The label states the tablet contains sildenafil citrate equivalent to 50 mg sildenafil, with usage specified as RX only. Packaging format is one tablet per unit dose pouch with temperature and storage instructions. The label includes manufacturing, distribution, and repackaging details by Pfizer Ireland Pharmaceuticals, Greenstone LLC, and Unit Dose Services respectively, plus handling warnings and contact information.*

FDA Label Image

Lbl504360036

Sildenafil Citrate 100 mg unit dose pouch label by Unit Dose Services. The label includes dosing, storage, and dispensing instructions, specifies each tablet contains sildenafil citrate equivalent to 100 mg sildenafil, and notes packaging details with a case count of 1,080 pouches. Barcode and contact information for questions are also present.*

FDA Label Image

Chemical Structure (Sildenafil 01)

FDA Label Image

Figure 1 (Sildenafil 02)

A line graph comparing the effect of Sildenafil 100mg versus placebo on systolic blood pressure over 24 hours. The x-axis shows time post dose in hours, and the y-axis shows systolic blood pressure changes in mmHg. Two lines represent Sildenafil and placebo data points with different markers.*

FDA Label Image

Figure 2 (Sildenafil 03)

A line graph showing change in seated diastolic blood pressure (SBP) over time (hours) postdose, comparing two conditions: doxazosin + placebo (blue line) and doxazosin + sildenafil 25 mg (black line). The y-axis represents change in SBP in mmHg, and the x-axis represents time postdose in hours.*

FDA Label Image

Figure 3 (Sildenafil 04)

Line graph showing change in systolic blood pressure (SBP) over time postdose (hours) comparing two treatments: Doxazosin with placebo and Doxazosin with Sildenafil 50 mg. The y-axis represents SBP change in mm Hg, and the x-axis shows time postdose in hours, with data points for each treatment indicated by different colored lines and markers.*

FDA Label Image

Figure 4 (Sildenafil 05)

A line graph showing blood pressure changes in mmHg over time (hours) after dosing with a combination of Doxazosin and Sildenafil 100 mg versus Doxazosin plus placebo. The x-axis represents time after dosing (0 to 8 hours) and the y-axis shows blood pressure values ranging from -50 to 40 mmHg. Two curves compare the effects of the two treatments.*

FDA Label Image

Figure 5 (Sildenafil 06)

A line graph depicting plasma concentration (ng/ml) of Sildenafil Citrate over time (hours) post-dose up to 24 hours after administration. The data shown are for a commercial tablet, with plasma levels peaking shortly after dosing and then gradually decreasing over time.*

FDA Label Image

Figure 6 (Sildenafil 07)

Two bar charts display the effect of Sildenafil Citrate and placebo on maintenance of erection by baseline score. The top chart shows percentages of patients by baseline score from 0 to 5 for Sildenafil Citrate; the bottom chart shows similar data for placebo. Each bar category is color-coded by erection maintenance score at endpoint.*

FDA Label Image

Figure 7 (Sildenafil 08)

A bar graph showing the percentage of patients reporting improvement across different treatment groups. The placebo group shows 24% improvement. Sildenafil Citrate at 25 mg has 63%, at 50 mg has 74%, and at 100 mg has 82% improvement. The x-axis lists treatment groups with sample sizes; the y-axis shows percentage improvement from 0 to 100%. An overall treatment significance of p<0.0001 is noted.*

FDA Label Image

Greenstone Logo (Sildenafil 09)

Label showing Greenstone Brand distributed by Greenstone LLC, Peapack, NJ 07977. The label is related to Sildenafil Citrate product by Unit Dose Services.*

FDA Label Image

Greenstone Logo (Sildenafil 10)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.